-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RLZLcuWsgLcLf24xmvQU73+wUdx6tPhVPii2zJ76VtRIONOIY3i8OqhOPdKQyHPd xKvMa2NooF4pnuA+P0acrQ== 0000926274-09-000107.txt : 20091022 0000926274-09-000107.hdr.sgml : 20091022 20091022153230 ACCESSION NUMBER: 0000926274-09-000107 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091022 DATE AS OF CHANGE: 20091022 GROUP MEMBERS: BA VALUE INVESTORS, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VAXGEN INC CENTRAL INDEX KEY: 0001036968 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943236309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-56525 FILM NUMBER: 091132470 BUSINESS ADDRESS: STREET 1: 379 OYSTER POINT STREET 2: SUITE 10 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-1000 MAIL ADDRESS: STREET 1: 379 OYSTER POINT STREET 2: SUITE 10 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BRONSON STEVEN N CENTRAL INDEX KEY: 0001000383 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SC 13D/A 1 vaxgen-13da3.txt SCHEDULE 13DA AMEND. NO. 3 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO SECTION 240.13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO SECTION 240.13D-2(A) (Amendment No. 3) VaxGen, Inc. ---------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.01 par share ---------------------------------------------------- (Title of Class of Securities) 922390208 ---------------------------------------------------- (CUSIP Number) Steven N. Bronson BA Value Investors, LLC 1 North Federal Highway, Suite 201 Boca Raton, Florida 33432 ---------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 19, 2009 ---------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. SCHEDULE 13D CUSIP No. 922390208 - ------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). BA Value Investors, LLC IRS ID No. 35-2240946 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) NA - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization Florida - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power 1,220,439 Shares Bene- ---------------------------------------------------------- ficially Owned 8. Shared Voting Power None By Each ---------------------------------------------------------- Reporting 9. Sole Dispositive Power 1,220,439 Person With ---------------------------------------------------------- 10. Shared Dispositive Power None - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,220,439 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 3.7% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) OO - -------------------------------------------------------------------------------- SCHEDULE 13D CUSIP No. 922390208 - ------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Steven N. Bronson - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) NA - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization United States of America - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power 1,220,439 Shares Bene- ---------------------------------------------------------- ficially Owned 8. Shared Voting Power None By Each ---------------------------------------------------------- Reporting 9. Sole Dispositive Power 1,220,439 Person With ---------------------------------------------------------- 10. Shared Dispositive Power None - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,220,439 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 3.7% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D--AMENDMENT NO. 3 This Amendment No. 3 filed by BA Value Investors, LLC and Steven N. Bronson (the "Reporting Persons") amends the Schedule 13D filed with the Securities and Exchange Commission by the Reporting Persons on August 27, 2009, as amended, with respect to the common stock, par value $0.01 per share, of VaxGen, Inc. (the "Company"). Item 4. Purpose of Transaction. Item 4 of the Schedule 13D is hereby supplemented as follows: Following announcement by the Company that it had entered into a merger agreement with OXiGENE, Inc., on October 19, 2009, BA Value Investors and ROI Capital Management determined to disband the VaxGen Full Value Committee. Thus, BA Value Investors, at this time, is not pursuing the previously announced intention to nominate directors to the Company's board. The decision to disband the Committee should not be interpreted as support for the proposed merger by either of BA Value Investors or ROI Capital Management. As a result of their decision to disband the Committee, as of October 19, 2009, BA Value Investors and ROI Capital Management have ceased to act as a group with respect to the securities of the Company. Item 5. Interest in Securities of the Issuer (a) The Reporting Persons interest in this Company is as follows: BA Value Investors beneficially owns 1,220,439 shares or approximately 3.7% of the Company's outstanding shares of Common Stock. - ---------- (1) Based upon 33,106,523 shares of Common Stock issued and outstanding as of July 31, 2009, as reported by the Company in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2009. (b) BA Value Investors may be deemed to have sole voting and dispositive power over the shares of Common Stock owned by BA Value Investors. Mr. Bronson may be deemed to have sole voting and dispositive power over the shares of Common Stock owned by BA Value Investors. (c) None of the reporting persons have engaged in transactions in the securities of the issuer during the past sixty (60) days, except for- Shares of Common Stock sold by BA Value Investors in the open market as follows: - ------------------------------------------------------------------------------- Date Number of Shares Price Per Share Total - ------------------------------------------------------------------------------- 10/20/2009 288,900 0.633 $182,115 - ------------------------------------------------------------------------------- 10/21/2009 312,661 0.6121 $190,871 - ------------------------------------------------------------------------------- (d) Not applicable. (e) On October 20, 2007, BA Value Investors and Mr. Bronson ceased to be the beneficial owners of more than 5% of the Company 's securities. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 22, 2009 BA Value Investors, LLC By: /s/ Steven N. Bronson --------------------------- Name: Steven N. Bronson Title: Managing Member /s/ Steven N. Bronson ------------------------------- Steven N. Bronson -----END PRIVACY-ENHANCED MESSAGE-----